2024 Q2 Form 10-Q Financial Statement

#000165856624000053 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $1.246B $1.243B $1.123B
YoY Change 99.89% 101.7% 47.41%
Cost Of Revenue $252.7M $264.8M $214.8M
YoY Change 91.62% 115.31% 68.49%
Gross Profit $993.3M $978.2M $907.9M
YoY Change 102.1% 98.33% 43.2%
Gross Profit Margin 79.72% 78.69% 80.87%
Selling, General & Admin $49.24M $37.91M $39.46M
YoY Change -7.79% 3.58% -48.61%
% of Gross Profit 4.96% 3.88% 4.35%
Research & Development $5.465M $10.95M $4.331M
YoY Change 18.8% 242.22% 20.31%
% of Gross Profit 0.55% 1.12% 0.48%
Depreciation & Amortization $426.4M $410.2M $367.4M
YoY Change 97.69% 117.95% 101.77%
% of Gross Profit 42.93% 41.93% 40.47%
Operating Expenses $790.9M $774.1M $442.5M
YoY Change 83.09% 103.63% 56.54%
Operating Profit $455.1M $469.0M $465.3M
YoY Change 137.78% 98.58% 32.46%
Interest Expense $75.45M $72.59M $127.7M
YoY Change 104.89% 97.37% -228.43%
% of Operating Profit 16.58% 15.48% 27.43%
Other Income/Expense, Net -$63.96M -$190.5M $1.648M
YoY Change 302.09% -1166.84% 449.33%
Pretax Income $391.2M $278.6M $491.5M
YoY Change 122.89% 9.64% 105.14%
Income Tax $82.27M $48.96M $78.89M
% Of Pretax Income 21.03% 17.58% 16.05%
Net Earnings $235.1M $146.6M $255.4M
YoY Change 220.3% 43.53% 207.29%
Net Earnings / Revenue 18.87% 11.79% 22.74%
Basic Earnings Per Share $0.38 $0.27
Diluted Earnings Per Share $0.36 $0.25 $0.51
COMMON SHARES
Basic Shares Outstanding 769.9M shares 552.5M shares
Diluted Shares Outstanding 656.4M shares 595.4M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $47.85M $12.69M $73.29M
YoY Change 161.47% -50.42% 23.18%
Cash & Equivalents $47.85M $12.69M $73.29M
Short-Term Investments
Other Short-Term Assets $32.13M $37.44M $96.04M
YoY Change -67.25% -67.94% -20.89%
Inventory
Prepaid Expenses
Receivables $287.7M $390.4M $477.4M
Other Receivables $2.265M $1.421M $3.690M
Total Short-Term Assets $578.1M $607.4M $650.4M
YoY Change 35.7% 36.8% 40.23%
LONG-TERM ASSETS
Property, Plant & Equipment $44.77M $45.01M $43.65M
YoY Change 15.6% 176.22% 187.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $154.5M $145.2M $176.1M
YoY Change 48.52% 90.3% 135.99%
Total Long-Term Assets $14.83B $14.47B $14.32B
YoY Change 74.47% 74.82% 78.3%
TOTAL ASSETS
Total Short-Term Assets $578.1M $607.4M $650.4M
Total Long-Term Assets $14.83B $14.47B $14.32B
Total Assets $15.41B $15.08B $14.97B
YoY Change 72.62% 72.89% 76.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $46.27M $43.51M $94.53M
YoY Change -54.87% -68.05% 83.76%
Accrued Expenses $552.6M $492.9M $578.5M
YoY Change 72.96% 95.3% 100.88%
Deferred Revenue $505.2M $493.8M $527.5M
YoY Change 83.13% 85.5% 110.89%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $762.0K $758.0K $753.0K
YoY Change
Total Short-Term Liabilities $1.168B $1.112B $1.242B
YoY Change 61.56% 63.06% 105.02%
LONG-TERM LIABILITIES
Long-Term Debt $3.887B $3.924B $3.864B
YoY Change 88.68% 92.1% 80.47%
Other Long-Term Liabilities $72.14M $69.77M $73.15M
YoY Change 8.65% 36.9% 2178.11%
Total Long-Term Liabilities $72.14M $69.77M $73.15M
YoY Change 8.65% 36.9% 2178.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.168B $1.112B $1.242B
Total Long-Term Liabilities $72.14M $69.77M $73.15M
Total Liabilities $5.749B $5.733B $5.736B
YoY Change 91.61% 96.71% 102.23%
SHAREHOLDERS EQUITY
Retained Earnings $735.0M $626.9M $569.1M
YoY Change 102.0% 93.69% 139.91%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.346B $6.958B $6.336B
YoY Change
Total Liabilities & Shareholders Equity $15.41B $15.08B $14.97B
YoY Change 72.62% 72.89% 76.22%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $235.1M $146.6M $255.4M
YoY Change 220.3% 43.53% 207.29%
Depreciation, Depletion And Amortization $426.4M $410.2M $367.4M
YoY Change 97.69% 117.95% 101.77%
Cash From Operating Activities $938.4M $647.6M $846.0M
YoY Change 109.24% 47.78% 60.14%
INVESTING ACTIVITIES
Capital Expenditures $517.6M $522.4M $461.9M
YoY Change 29.7% 65.05% 23.49%
Acquisitions
YoY Change
Other Investing Activities -$158.0M -$96.95M -$21.33M
YoY Change 1826.32% -497.35% -132.62%
Cash From Investing Activities -$675.6M -$619.3M -$483.2M
YoY Change 65.87% 112.01% 56.58%
FINANCING ACTIVITIES
Cash Dividend Paid $87.19M
YoY Change 473.95%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -227.7M -$88.84M -501.2M
YoY Change 369.41% -53.21% 155.98%
NET CHANGE
Cash From Operating Activities 938.4M $647.6M 846.0M
Cash From Investing Activities -675.6M -$619.3M -483.2M
Cash From Financing Activities -227.7M -$88.84M -501.2M
Net Change In Cash 35.17M -$60.59M -138.4M
YoY Change -581.78% 38.39% -679.13%
FREE CASH FLOW
Cash From Operating Activities $938.4M $647.6M $846.0M
Capital Expenditures $517.6M $522.4M $461.9M
Free Cash Flow $420.8M $125.2M $384.1M
YoY Change 751.8% 2.87% 148.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17871000 usd
CY2024Q1 us-gaap Production Tax Expense
ProductionTaxExpense
96166000 usd
CY2023Q1 us-gaap Production Tax Expense
ProductionTaxExpense
48509000 usd
CY2024Q1 pr Oil And Gas Producing Activities Transportation Costs
OilAndGasProducingActivitiesTransportationCosts
39055000 usd
CY2023Q1 pr Oil And Gas Producing Activities Transportation Costs
OilAndGasProducingActivitiesTransportationCosts
15482000 usd
CY2024Q1 pr Depreciation Depletion Amortization And Asset Retirement Obligation Accretion Expense
DepreciationDepletionAmortizationAndAssetRetirementObligationAccretionExpense
410179000 usd
CY2023Q1 pr Depreciation Depletion Amortization And Asset Retirement Obligation Accretion Expense
DepreciationDepletionAmortizationAndAssetRetirementObligationAccretionExpense
188219000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37373000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35474000 usd
CY2024Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
11123000 usd
CY2023Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
13299000 usd
CY2024Q1 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
20000 usd
CY2023Q1 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
245000 usd
CY2024Q1 us-gaap Exploration Expense
ExplorationExpense
11488000 usd
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
4374000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
774075000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
380134000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
112000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
66000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
469036000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
236200000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
72587000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
36777000 usd
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-121129000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
54512000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3232000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
120000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-190484000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17855000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
278552000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
254055000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48957000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34254000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
229595000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
219801000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
83020000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
117681000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
146575000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
102120000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2024Q1 us-gaap Profit Loss
ProfitLoss
229595000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
219801000 usd
CY2024Q1 pr Depreciation Depletion Amortization And Asset Retirement Obligation Accretion Expense
DepreciationDepletionAmortizationAndAssetRetirementObligationAccretionExpense
410179000 usd
CY2023Q1 pr Depreciation Depletion Amortization And Asset Retirement Obligation Accretion Expense
DepreciationDepletionAmortizationAndAssetRetirementObligationAccretionExpense
188219000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9631000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
17871000 usd
CY2024Q1 us-gaap Exploration Abandonment And Impairment Expense
ExplorationAbandonmentAndImpairmentExpense
20000 usd
CY2023Q1 us-gaap Exploration Abandonment And Impairment Expense
ExplorationAbandonmentAndImpairmentExpense
245000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
46979000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
33454000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
112000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
66000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-128474000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
14777000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1531000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2796000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
85138000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1503000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5350000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1016000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-98911000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6811000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
647598000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
438213000 usd
CY2024Q1 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
97019000 usd
CY2023Q1 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
100755000 usd
CY2024Q1 us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
519623000 usd
CY2023Q1 us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
315285000 usd
CY2024Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
2772000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1204000 usd
CY2024Q1 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
60000000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
66000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
65116000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-619348000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-292128000 usd
CY2024Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
220000000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
160000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
160000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
260000000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1880000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
58000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
231000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
31492000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
61578000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
87194000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
15192000 usd
CY2024Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
28327000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
13324000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-88835000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-189863000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-60585000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-43778000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73864000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69932000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13279000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26154000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
92331000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
48521000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
800000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
258587000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
215709000 usd
CY2024Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
0 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
24801000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
7147000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
601000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5093000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1535000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12692000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25593000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
587000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
561000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13279000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26154000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9229748000 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
31492000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9631000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
58000 usd
CY2024Q1 us-gaap Dividends
Dividends
88784000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
28327000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
26277000 usd
CY2024Q1 pr Equity Impact Tax Expense Benefit
EquityImpactTaxExpenseBenefit
1500000 usd
CY2024Q1 pr Adjustments To Additional Paid In Capital Equity Impact
AdjustmentsToAdditionalPaidInCapitalEquityImpact
-1490000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
229595000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9348196000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
32160000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
29418000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
241000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
231000 usd
CY2023Q1 us-gaap Dividends
Dividends
15669000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
13950000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2416000 usd
CY2023Q1 pr Equity Impact Tax Expense Benefit
EquityImpactTaxExpenseBenefit
-3000000 usd
CY2023Q1 pr Adjustments To Additional Paid In Capital Equity Impact
AdjustmentsToAdditionalPaidInCapitalEquityImpact
-3027000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
219801000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5808686000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s consolidated financial statements requires the Company’s management to make various assumptions, judgments and estimates to determine the reported amounts of assets, liabilities, revenues and expenses, and the disclosures of commitments and contingencies. Changes in these assumptions, judgments and estimates will occur as a result of the passage of time and the occurrence of future events, and accordingly, actual results could differ from amounts previously established. Additionally, the prices received for oil, natural gas and NGL production can heavily influence the Company’s assumptions, judgments and estimates, and continued volatility of oil and gas prices could have a significant impact on the Company’s estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The more significant areas requiring the use of assumptions, judgments and estimates include: (i) oil and natural gas reserves; (ii) cash flow estimates used in impairment tests for long-lived assets; (iii) impairment expense of unproved properties; (iv) depreciation, depletion and amortization; (v) asset retirement obligations; (vi) determining fair value and allocating purchase price in connection with business combinations and asset acquisitions; (vii) accrued revenues and related receivables; (viii) accrued liabilities; (ix) derivative valuations; (x) deferred income taxes; and (xi) determining the fair values of certain stock-based compensation awards.</span></div>
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
123147000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
59359000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
15150000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
15189000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
53172000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
33006000 usd
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
758000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
753000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
71898000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28302000 usd
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
14909000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
14821000 usd
CY2024Q1 us-gaap Asset Acquisition Consideration Transferred Transaction Cost
AssetAcquisitionConsiderationTransferredTransactionCost
1700000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
390421000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
345982000 usd
CY2024Q1 us-gaap Oil And Gas Joint Interest Billing Receivables Current
OilAndGasJointInterestBillingReceivablesCurrent
164730000 usd
CY2023Q4 us-gaap Oil And Gas Joint Interest Billing Receivables Current
OilAndGasJointInterestBillingReceivablesCurrent
123160000 usd
CY2024Q1 us-gaap Hedging Assets Current
HedgingAssetsCurrent
671000 usd
CY2023Q4 us-gaap Hedging Assets Current
HedgingAssetsCurrent
8228000 usd
CY2024Q1 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
1421000 usd
CY2023Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
3690000 usd
CY2024Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
557243000 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
481060000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
43511000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
94533000 usd
CY2024Q1 pr Accrued Capital Expenditures
AccruedCapitalExpenditures
239440000 usd
CY2023Q4 pr Accrued Capital Expenditures
AccruedCapitalExpenditures
271569000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
493841000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
527470000 usd
CY2024Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
14995000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
29836000 usd
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
79050000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
100882000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
106277000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
143235000 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
977114000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1167525000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
3909418000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
3848781000 usd
CY2024Q1 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
121417000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
3507000 usd
CY2024Q1 pr Asset Retirement Obligation Liabilities Acquired
AssetRetirementObligationLiabilitiesAcquired
3640000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
2549000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
2145000 usd
CY2024Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
128160000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9631000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17871000 usd
CY2024Q1 pr Number Of Employees Terminated
NumberOfEmployeesTerminated
0 employee
CY2023Q1 pr Number Of Employees Terminated
NumberOfEmployeesTerminated
9 employee
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
6300000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
681699 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.64
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7500 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.58
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
25000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
18.60
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
649199 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.67
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1189000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
649199 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.67
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y6M
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1189000 usd
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-121129000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
54512000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2024Q1 pr Cash Dividends And Nci Distributions
CashDividendsAndNCIDistributions
115521000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2023Q1 pr Cash Dividends And Nci Distributions
CashDividendsAndNCIDistributions
28516000 usd
CY2024Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-31400000 usd
CY2023Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-29400000 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2000000 shares
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2800000 shares
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
146575000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
102120000 usd
CY2024Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
1322000 usd
CY2023Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
1375000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
147897000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
103495000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
552472000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
295913000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
28355000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
27314000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
14525000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
12621000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
595352000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
335848000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2000000 shares
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2800000 shares
CY2024Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-31400000 usd
CY2023Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-29400000 usd
CY2024Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
6500000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1242999000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
616268000 usd
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
390400000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
346000000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001658566-24-000053-index-headers.html Edgar Link pending
0001658566-24-000053-index.html Edgar Link pending
0001658566-24-000053.txt Edgar Link pending
0001658566-24-000053-xbrl.zip Edgar Link pending
exhibit311q1-24.htm Edgar Link pending
exhibit312q1-24.htm Edgar Link pending
exhibit313q1-24.htm Edgar Link pending
exhibit321q1-24.htm Edgar Link pending
exhibit322q1-24.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pr-20240331.htm Edgar Link pending
pr-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pr-20240331_cal.xml Edgar Link unprocessable
pr-20240331_def.xml Edgar Link unprocessable
pr-20240331_lab.xml Edgar Link unprocessable
pr-20240331_pre.xml Edgar Link unprocessable
pr-20240331_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending